• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

Introduction to 6-Chloro-N4-Methylpyrimidine-4,5-diamine (CAS No. 52602-68-3)

6-Chloro-N4-methylpyrimidine-4,5-diamine, with the CAS number 52602-68-3, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrimidines, which are fundamental building blocks in nucleic acids and have a wide range of biological activities. The unique structural features of 6-chloro-N4-methylpyrimidine-4,5-diamine make it a valuable intermediate in the synthesis of various bioactive molecules, including potential therapeutic agents.

The chemical structure of 6-chloro-N4-methylpyrimidine-4,5-diamine consists of a pyrimidine ring with a chlorine atom at the 6-position and a methylamino group at the 4-position. The presence of these functional groups imparts specific chemical and biological properties to the molecule, making it an attractive target for synthetic chemists and drug developers. Recent studies have highlighted its potential in modulating various biological pathways, particularly those involved in inflammation and cancer.

In the realm of medicinal chemistry, 6-chloro-N4-methylpyrimidine-4,5-diamine has been explored as a lead compound for the development of novel anti-inflammatory agents. Inflammation is a complex biological response to harmful stimuli and is a key factor in many diseases, including arthritis, asthma, and inflammatory bowel disease. Research has shown that derivatives of 6-chloro-N4-methylpyrimidine-4,5-diamine can effectively inhibit pro-inflammatory cytokines and enzymes, thereby reducing inflammation and associated symptoms.

Beyond its anti-inflammatory properties, 6-chloro-N4-methylpyrimidine-4,5-diamine has also shown promise in cancer research. Pyrimidine derivatives are known for their ability to interfere with DNA synthesis and cell division, making them potential candidates for anticancer drugs. Studies have demonstrated that certain derivatives of 6-chloro-N4-methylpyrimidine-4,5-diamine exhibit selective cytotoxicity against various cancer cell lines, including those resistant to conventional chemotherapy. This selective toxicity is attributed to the unique structural features of the molecule, which allow it to target specific cellular pathways involved in cancer progression.

The synthesis of 6-chloro-N4-methylpyrimidine-4,5-diamine involves several well-established chemical reactions. One common approach is the condensation of 2-amino-4-chloropyrimidine with methylamine followed by further functionalization steps to introduce the desired substituents. The versatility of this synthetic route allows for the preparation of a wide range of derivatives with varying biological activities. Recent advancements in synthetic methods have also led to more efficient and environmentally friendly processes for producing this compound on a larger scale.

In addition to its therapeutic potential, 6-chloro-N4-methylpyrimidine-4,5-diamine has been studied for its use as a probe molecule in biochemical assays. Its ability to interact with specific proteins and enzymes makes it useful for understanding molecular mechanisms underlying various diseases. For instance, it has been used to investigate the role of certain kinases in signal transduction pathways, providing valuable insights into potential drug targets.

The safety profile of 6-chloro-N4-methylpyrimidine-4,5-diamine is an important consideration in its development as a pharmaceutical agent. Preclinical studies have shown that it exhibits low toxicity and good pharmacokinetic properties, making it suitable for further evaluation in clinical trials. However, ongoing research is necessary to fully understand its long-term effects and potential side effects.

In conclusion, 6-chloro-N4-methylpyrimidine-4,5-diamine (CAS No. 52602-68-3) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and biological activities make it an attractive candidate for the development of novel therapeutic agents targeting inflammation and cancer. Continued research into this compound will likely uncover additional applications and contribute to advancements in drug discovery and development.

• 89580-84-7(6-chloro-N4-ethylpyrimidine-2,4,5-triamine)
• 41259-67-0(N'4'-Butyl-6-chloro-pyrimidine-4,5-diamine)
• 4316-98-7(6-Chloropyrimidine-4,5-diamine)
• 18202-82-9(6-chloro-4-N-(propan-2-yl)pyrimidine-4,5-diamine)
• 130623-81-3(6-Chloro-N4,N4-dimethylpyrimidine-4,5-diamine)
• 195252-62-1(6-chloro-N4-cyclopropylpyrimidine-4,5-diamine)
• 195252-56-3(6-chloro-4-N-propylpyrimidine-4,5-diamine)
• 6623-88-7(2-(5-Amino-6-chloro-pyrimidin-4-ylamino)-ethanol)
• 41259-65-8(6-Chloro-N4-phenylpyrimidine-4,5-diamine)
• 98140-03-5(6-chloro-N4-ethylpyrimidine-4,5-diamine)